# Varda Space Industries expansion and funding

> Live situation record from CLSTR: https://clstr.news/situations/varda-space-industries-expansion-and-funding
> Updated: 2026-10-21T14:12:55.000Z. Sources: 8. Developments: 2.

Varda Space Industries has secured $251 million in Series D funding, led by Lux Capital and Natural Capital, bringing its total capital raised to nearly $600 million. The company is valued at $1.6 billion.

The investment is intended to scale orbital pharmaceutical manufacturing and space-to-Earth reentry infrastructure. Varda utilizes microgravity to develop drug formulations, such as cancer medications, that achieve improved solubility and crystallization patterns difficult to replicate on Earth.

In conjunction with this funding, the company is advancing its mission cadence. Recent and upcoming activities include the W-7 mission to study the crystallization of PROTACs and planned launches such as the W-8 and W-9 missions to support pharmaceutical, semiconductor, and national security research.

## Claims

- Varda Space Industries secured $251 million in a Series D funding round. (corroborated by 3 sources)
- The Series D round was led by Lux Capital and Natural Capital. (corroborated by 3 sources)
- Varda Space Industries has a total capital of $598 million. (corroborated by 3 sources)
- The company's valuation is $1.6 billion. (corroborated by 3 sources)
- The W-7 spacecraft was launched on a SpaceX Falcon 9 from Cape Canaveral. (corroborated by 3 sources)
- The W-7 mission focuses on the crystallization of PROTAC cancer drugs in microgravity. (corroborated by 3 sources)

## Timeline

### 2026-10-21: Varda Space Industries secures $251 million for space-based drug research

Varda Space Industries raised $251 million to advance pharmaceutical research in space, focusing on improving the solubility of cancer drugs like PROTACs through microgravity crystallization.

4 sources. https://clstr.news/cluster/varda-space-industries-secures-251-million-for-space-based-drug-research

### 2026-09-30: Varda Space Industries raises $251M to scale orbital pharmaceutical manufacturing

Varda Space Industries raised $251 million in Series D funding to scale pharmaceutical manufacturing in orbit and expand its space-to-Earth reentry capabilities.

3 sources. https://clstr.news/cluster/varda-space-industries-raises-251m-to-scale-orbital-pharmaceutical-manufacturing

---
Cite as: Varda Space Industries expansion and funding. CLSTR, https://clstr.news/situations/varda-space-industries-expansion-and-funding